Skip to main content

Table 2 Sonographic features of tumours in 620 women with adnexal masses

From: Estimating the risk of malignancy of adnexal masses: validation of the ADNEX model in the hands of nonexpert ultrasonographers in a gynaecological oncology centre in China

Characteristic

Malignant (n = 218)

Benign (n = 402)

Borderline (n = 86)

Stage I OC (n = 75)

Stage II–IV OC (n = 53)

Metastasis (n = 4)

Total (n = 620)

p

Age (years)

31 (27–39)

38 (30–48)

47 (41–53)

48 (44–57)

57 (46–62)

44 (34–52)

< 0.001*

CA 125 (U/mL)

11.4 (8–17)

18 (10–28)

37 (15–83)

204 (53–547)

66 (28–137)

26 (13–74)

< 0.001 *

Max diameter of lesion (mm)

63 (50–83)

88 (53–121)

106 (71–148)

88 (64–143)

81 (63–108)

92 (64–133)

< 0.001*

Presence of solid tissue

44 (10.9)

63 (73.3)

70 (93.3)

53 (100)

4 (100)

190 (30.6)

< 0.001 †

Maximum diameter of largest solid component, if present (mm)

30 (13–48)

31 (21–49)

46 (31–80)

66 (57–79)

74 (48–107)

45 (26–67)

p = 0.001*

Papillary projections present

15 (3.7)

45 (52.3)

36 (48.0)

28 (52.8)

0 (0)

109 (17.6)

< 0.001‡

 0

387 (96.3)

41 (47.7)

39 (52.0)

25 (47.2)

4 (100)

109 (17.6)

 

 1

11 (2.7)

31 (36.0)

23 (30.7)

8 (15.1)

0 (0)

62 (10.0)

 

 2

2 (0.5)

7 (8.1)

3 (4.0)

4 (7.5)

0 (0)

14 (2.3)

 

 3

1 (0.2)

3 (3.5)

4 (5.3)

5 (9.4)

0 (0)

12 (1.9)

 

 > 3

1 (0.2)

4 (4.7)

6 (8.0)

11 (20.8)

0 (0)

21 (3.4)

 

 > 10 cyst locules

3 (0.7)

15 (17.4)

8 (10.7)

4 (7.5)

0 (0)

27 (4.4)

< 0.001 †

Acoustic shadows

121 (30.1)

1 (1.2)

5 (6.7)

2 (3.8)

0 (0)

8 (1.3)

< 0.001 †

Ascites

3 (0.7)

4 (4.7)

11 (14.7)

30 (56.6)

3 (75.0)

48 (7.7)

< 0.001 †

  1. Data are given as the median (interquartile range) or n (%)
  2. OC Ovarian cancer
  3. P for benign vs. malignant group calculated using the following tests: *Mann–Whitney U-test, †chi-square test or ‡Fisher’s exact test